BRIEF-Ligand says partner Lundbeck plans to make Carnexiv commercially available in U.S. in early 2017
October 07, 2016 at 19:44 PM EDT
* Partner Lundbeck receives FDA approval of Carnexiv(tm) (carbamazepine) injection as intravenous short-term replacement therapy for certain seizure types
